Related Experiment Video
Updated: Sep 9, 2025

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease
Ismail Elkhattib1, Kareem Wael Raafat2, Basant Elsayed3
1Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68105, United States. ismailkhattib89@gmail.com.
Insights
Hepatitis C virus (HCV) infection is linked to cardiovascular issues like atherosclerosis and cardiomyopathy. Viral load and steatosis are key risk factors, highlighting the need for further research into HCV and heart disease.
Area of Science:
- Cardiovascular Medicine
- Hepatology
- Virology
Background:
- Hepatitis C virus (HCV) infection is primarily known for liver disease but is increasingly linked to cardiovascular complications.
- Carotid atherosclerosis and cardiomyopathy are significant cardiovascular issues associated with chronic HCV infection.
Purpose of the Study:
- To explore the association between Hepatitis C virus infection and cardiovascular complications.
- To investigate the mechanisms underlying HCV-related atherosclerosis and cardiomyopathy.
- To identify risk factors and understand the pathogenesis of cardiovascular disease in HCV patients.
Main Methods:
- Review of studies investigating cardiovascular outcomes in patients with chronic Hepatitis C virus infection.
- Analysis of risk factors such as viral load and steatosis.
- Examination of molecular and cellular mechanisms including inflammation, oxidative stress, and immune responses.
Main Results:
- Chronic HCV infection is associated with a higher prevalence of carotid atherosclerosis, with viral load and steatosis as independent risk factors.
- HCV-related atherosclerosis involves endothelial dysfunction, inflammation (TNF-α, IL-6), oxidative stress (malondialdehyde), and immune dysregulation.
- HCV infection contributes to cardiomyopathy through direct viral effects on cardiomyocytes and indirect immune-mediated damage, alongside a procoagulant imbalance (elevated Factor VIII).
Conclusions:
- Substantial evidence links Hepatitis C virus infection to cardiovascular disease, including atherosclerosis and cardiomyopathy.
- Mechanisms involve direct viral impact, inflammation, oxidative stress, immune responses, and altered coagulation.
- Further research is required to confirm causality and inform therapeutic strategies for cardiovascular risk in HCV patients.
Abstract:
Hepatitis C virus (HCV) infection has been increasingly associated with cardiovascular complications, particularly atherosclerosis and cardiomyopathy, in addition to its primary hepatic effects. Studies indicate a higher prevalence of carotid atherosclerosis in patients with chronic hepatitis C infection, with viral load and steatosis emerging as independent risk factors. HCV-related atherosclerosis appears to develop through complex processes involving endothelial dysfunction, inflammation, oxidative stress, and immune dysregulation. Key cytokines, including tumor necrosis factor-alpha and interleukin-6, increase inflammatory responses, while oxidative stress markers, such as malondialdehyde, are associated with an increased risk of atherogenesis. In addition, HCV infection has been linked to cardiomyopathy. Direct viral effects, including HCV replication within cardiomyocytes and cytotoxicity induced by viral proteins, lead to myocardial injury and functional decline. Indirectly, HCV triggers immune-mediated damage, with heightened pro-inflammatory cytokines exacerbating cardiomyocyte apoptosis and fibrosis. Furthermore, HCV infection promotes a procoagulant imbalance, as evidenced by elevated factor VIII levels and thrombin potential, contributing to the increased cardiovascular risk. While substantial evidence indicates a relationship between HCV and cardiovascular disease, further research is needed to establish causality and guide therapeutic interventions.
Related Concept Videos
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis I: Introduction
Cardiomyopathy I: Introduction and Classification

